{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:31:12Z","timestamp":1791156672141,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":2730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"crossref","award":["R01-HS016743"],"award-info":[{"award-number":["R01-HS016743"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1093\/annonc\/mdr449","type":"journal-article","created":{"date-parts":[[2011,10,23]],"date-time":"2011-10-23T00:25:31Z","timestamp":1319329531000},"page":"1503-1511","source":"Crossref","is-referenced-by-count":25,"title":["Comparison of toxicity profiles of fluorouracil versus oxaliplatin regimens in a large population-based cohort of elderly patients with colorectal cancer"],"prefix":"10.1016","volume":"23","author":[{"given":"P.","family":"Cen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.L.","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdr449_bb0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1093\/annonc\/mdr449_bb0015","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1200\/JCO.1999.17.8.2412","article-title":"Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older","volume":"17","author":"Popescu","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0020","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa010957","article-title":"A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients","volume":"345","author":"Sargent","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdr449_bb0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.7326\/0003-4819-136-5-200203050-00007","article-title":"Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer","volume":"136","author":"Sundararajan","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdr449_bb0030","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1001\/jama.294.21.2703","article-title":"Adjuvant chemotherapy for stage III colon cancer: implications of race\/ethnicity, age, and differentiation","volume":"294","author":"Jessup","year":"2005","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdr449_bb0035","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1200\/JCO.2006.06.9039","article-title":"Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil\/leucovorin administered bimonthly in elderly patients with colorectal cancer","volume":"24","author":"Goldberg","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0040","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2007.14.0509","article-title":"Irinotecan\/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials","volume":"26","author":"Folprecht","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0045","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00432-009-0712-3","article-title":"Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies","volume":"136","author":"Cassidy","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0050","unstructured":"NMJackson McClearyJGreenEYothersImpact of older age on the efficacy of newer adjuvant therapies in >12,500 patients (pts) with stage II\/III colon cancer: findings from the ACCENT Database.In ASCO Annual Meeting, Edition 2009"},{"key":"10.1093\/annonc\/mdr449_bb0055","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial","volume":"27","author":"Andre","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0060","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1200\/JCO.2005.06.035","article-title":"Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study","volume":"23","author":"Feliu","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0065","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/jnci\/djm086","article-title":"Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab","volume":"99","author":"Scappaticci","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdr449_bb0070","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/annonc\/mdp233","article-title":"Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study","volume":"20","author":"Van Cutsem","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1200\/JCO.2008.17.7931","article-title":"Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials","volume":"27","author":"Kabbinavar","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0080","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1200\/JCO.2009.21.9220","article-title":"Initial safety report of NSABP C-08: a randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer","volume":"27","author":"Allegra","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0085","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"Underrepresentation of patients 65 years of age or older in cancer-treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdr449_bb0090","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1001\/jama.2010.272","article-title":"Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer","volume":"303","author":"Kahn","year":"2010","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdr449_bb0095","first-page":"1117","article-title":"The surveillance, epidemiology, and end results program: a national resource","volume":"8","author":"Hankey","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdr449_bb0100","unstructured":"ICD-0-3 SEER SITE\/HISTOLOGY VALIDATION LIST. http:\/\/seer.cancer.gov\/icd-o-3\/sitetype.icdo3.d20090401.pdf (1 April 2009, date last accessed)"},{"key":"10.1093\/annonc\/mdr449_bb0105","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/gerona\/glp180","article-title":"Comorbidities, functional limitations, and geriatric syndromes in relation to treatment and survival patterns among elders with colorectal cancer","volume":"65","author":"Koroukian","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1093\/annonc\/mdr449_bb0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.2003.07.125","article-title":"Impact of diabetes mellitus on outcomes in patients with colon cancer","volume":"21","author":"Meyerhardt","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0115","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1200\/JCO.2003.10.065","article-title":"Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial","volume":"21","author":"Andre","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0120","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1200\/JCO.2007.12.2234","article-title":"Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1","volume":"25","author":"Andre","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/annonc\/mdi116","article-title":"A randomised comparison between 6 months of bolus fluorouracil\/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer","volume":"16","author":"Chau","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0130","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1200\/JCO.2005.04.169","article-title":"Phase III Southwest Oncology Group 9415\/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer","volume":"23","author":"Poplin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr449_bb0135","unstructured":"CYHuWChanGPDelclosXLDuAdjuvant chemotherapy and risk of gastrointestinal, hematologic, and cardiac toxicities in elderly patients with stage III colon cancerAm J Clin Oncol2011 Mar 4. [Epub ahead of print]"},{"key":"10.1093\/annonc\/mdr449_bb0140","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(11)60399-1","article-title":"Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial","volume":"377","author":"Seymour","year":"2011","journal-title":"Lancet"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419387010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419387010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/6\/1503\/13785451\/mdr449.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T09:27:54Z","timestamp":1624699674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419387010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0923753419387010"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdr449","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}